Company: VCYT
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001384101-25-000051
Chunk: 75

Company: VERACYTE, INC.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 75
---
 McGuire: (i) a lump sum severance payment equal to 18 months of salary from the termination date, (ii) a lump sum payment equal to 150% the highest of his or her (A) annual target bonus for the year in which the change of control occurs, (B) annual target bonus for the year in which the termination occurs, or (C) actual bonus for the year prior to the year in which the termination occurs and (iii) accelerated vesting equal to 100% of any outstanding equity awards (and with respect to equity awards subject to performance, assuming “target” level performance, unless provided otherwise in the applicable PSU agreement) and (iv) up to 18 months continuation coverage under COBRA.

Upon a change in control of the company, the NEO may be subject to a reduction in compensation as a result of excise tax calculations under the best net after-tax severance approach pursuant to Section 4999 of the Code.

The receipt of the above-described benefits is subject to the NEO executing a release of certain claims against us.

The following table illustrates the potential payments and benefits our NEOs would be entitled to upon termination of employment or a Change in Control (“CIC”) under each situation listed below. The potential payments assume that the termination and/or termination resulting from a CIC occurred on December 31, 2024 and, where applicable, use the closing price of our Common Stock of $39.60 on December 31, 2024, the final trading day of the year. The table is merely an illustrative example of the impact of a hypothetical termination of employment or change in control and qualifying termination. The amounts that would actually be paid upon a termination of employment can only be determined at the time of such termination, based on the facts and circumstances then prevailing. The receipt of the above-described benefits is subject to the NEO executing a release of certain claims against us.

#### Veracyte2025 Proxy Statement65

#### Executive Compensation
|                  |     | Upon Qualifying Termination - 
 No Change in Control          |           |     |        |                                  |                              |   |     |       |           |     | Upon Qualifying Termination - 
 Change in Control             |           |     |        |                                  |                              |            |     |            |       |
| Name             |     | Cash Severance                
 ($)(1)                        |           |     |        | Continuation of Medical Benefits 
 ($)                              | Value of Accelerated Vesting 
 ($